Clinical Trial Results:
A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND-DOUBLE DUMMY STUDY, TO EVALUATE EFFICACY AND SAFETY OF TREATMENT WITH AZITHROMYCIN, MICROSPHERES, ORAL POWDER FOR SUSPENSION, 2 G, IN ONE ADMINISTRATION A WEEK, FOR 8 WEEKS, COMPARED WITH TREATMENT WITH MINOCYCLINE CAPSULES, 100 MG DIE FOR 8 WEEKS, IN OUTPATIENTS WITH MODERATE TO SEVERE INFLAMMATORY ACNE.
Summary
|
|
EudraCT number |
2006-003491-35 |
Trial protocol |
IT |
Global completion date |
03 Jul 2003
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Oct 2016
|
First version publication date |
08 Oct 2016
|
Other versions |
|
Summary report(s) |
A0661150_Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.